NEW YORK, Sept. 24 – Alpha Therapeutic said it has received US Food and Drug Administration approval to use polymerase chain reaction technology to screen plasma donations for HIV-1 and hepatitis C.

The company, which made the announcement Friday, said it was the first company to receive such approval.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.